{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:40:06Z","timestamp":1790635206176,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamaophthalmol.2018.3352","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T21:40:42Z","timestamp":1534801242000},"page":"1170","source":"Crossref","is-referenced-by-count":54,"title":["Research Questions and Outcomes Prioritized by Patients With Dry Eye"],"prefix":"10.1001","volume":"136","author":[{"given":"Ian J.","family":"Saldanha","sequence":"first","affiliation":[{"name":"Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Petris","sequence":"additional","affiliation":[{"name":"Dry Eye Company LLC, Poulsbo, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Han","sequence":"additional","affiliation":[{"name":"Consumers United for Evidence-Based Healthcare, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Dickersin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Reviews Editor, JAMA Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen K.","family":"Akpek","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"eoi180066r1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report.","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"eoi180066r2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.6.3.24","article-title":"Impact of glaucoma and dry eye on text-based searching.","volume":"6","author":"Sun","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"eoi180066r3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact of quality of life and vision.","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"eoi180066r4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/OPTH","article-title":"Etiology, prevalence, and treatment of dry eye disease.","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"eoi180066r5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bjophthalmol-2015-308237","article-title":"Functional impairment of reading in patients with dry eye.","volume":"101","author":"Mathews","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi180066r6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjophthalmol-2013-303518","article-title":"Impact of dry eye on reading in a population-based sample of the elderly: the Salisbury Eye Evaluation.","volume":"98","author":"van Landingham","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi180066r7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/IJG.0b013e31829e5616","article-title":"Setting priorities for comparative effectiveness research on management of primary angle closure: a survey of Asia-Pacific clinicians.","volume":"24","author":"Yu","year":"2015","journal-title":"J Glaucoma"},{"issue":"4","key":"eoi180066r8","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi180066r9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"eoi180066r10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II Report Executive Summary.","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"12","key":"eoi180066r11","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/ICO.0000000000001350","article-title":"Gaps in current knowledge and priorities for future research in dry eye.","volume":"36","author":"Saldanha","year":"2017","journal-title":"Cornea"},{"issue":"6","key":"eoi180066r12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/bjophthalmol-2016-309955","article-title":"\u201cThe patient is speaking\u201d: discovering the patient voice in ophthalmology.","volume":"101","author":"Dean","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"eoi180066r13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","article-title":"Impact of dry eye disease and treatment on quality of life.","volume":"21","author":"Friedman","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"eoi180066r14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1542-0124(12)70086-1","article-title":"Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"issue":"9","key":"eoi180066r15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database--update and key issues.","volume":"364","author":"Zarin","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"eoi180066r16","doi-asserted-by":"publisher","first-page":"e109400","DOI":"10.1371\/journal.pone.0109400","article-title":"Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability.","volume":"9","author":"Saldanha","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"eoi180066r18","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ejso.2017.10.143","article-title":"Are the priorities of patients & researchers aligned in the reporting of outcomes in gastric cancer surgery trials?","volume":"43","author":"Alkhaffaf","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"eoi180066r19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/jamaophthalmol.2016.2101","article-title":"Assessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devices.","volume":"134","author":"Le","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"9683","key":"eoi180066r20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","article-title":"Avoidable waste in the production and reporting of research evidence.","volume":"374","author":"Chalmers","year":"2009","journal-title":"Lancet"},{"issue":"9913","key":"eoi180066r21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0140-6736(13)62228-X","article-title":"Reducing waste from incomplete or unusable reports of biomedical research.","volume":"383","author":"Glasziou","year":"2014","journal-title":"Lancet"},{"key":"eoi180066r22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jclinepi.2017.02.005","article-title":"Clinical trials and systematic reviews addressing similar interventions for the same condition do not consider similar outcomes to be important: a case study in HIV\/AIDS.","volume":"84","author":"Saldanha","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"eoi180066r23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II Clinical Trial Design Report.","volume":"15","author":"Novack","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"eoi180066r26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications.","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"eoi180066r27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11882-004-0077-2","article-title":"Dry eye: diagnosis and current treatment strategies.","volume":"4","author":"O\u2019Brien","year":"2004","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"eoi180066r28","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes.","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"eoi180066r29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider.","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"key":"eoi180066r30","doi-asserted-by":"publisher","first-page":"j2262","DOI":"10.1136\/bmj.j2262","article-title":"A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis.","volume":"357","author":"Kirkham","year":"2017","journal-title":"BMJ"},{"key":"eoi180066r31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0.","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"issue":"3","key":"eoi180066r32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report.","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"9","key":"eoi180066r33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/jamaophthalmol.2017.2583","article-title":"Comparison of clinical trial and systematic review outcomes for the 4 most prevalent eye diseases.","volume":"135","author":"Saldanha","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi180066r34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ceo.2014.42.issue-3","article-title":"Prevalence of dry eye syndrome in an adult population.","volume":"42","author":"Hashemi","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"eoi180066r35","doi-asserted-by":"publisher","first-page":"e005296","DOI":"10.1136\/bmjopen-2014-005296","article-title":"Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis.","volume":"4","author":"Hua","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"eoi180066r36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ajo.2013.05.040","article-title":"Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study.","volume":"156","author":"Uchino","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"eoi180066r17","unstructured":"The Dry Eye Zone. About. https:\/\/www.dryeyezone.com\/about\/. Accessed May 9, 2018."},{"key":"eoi180066r24","unstructured":"Food and Drug Administration. Center for Drug Evaluation and Research. Approval package for application number 21-023 (trade name: Restasis). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-023_Restasis_Approv.PDF. Accessed May 9, 2018."},{"key":"eoi180066r25","unstructured":"Food and Drug Administration. Center for Drug Evaluation and Research. Approval package for application number NDA 208073 (trade name: Xiidra). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2016\/208073Orig1s000ltr.pdf. Accessed May 9, 2018."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamaophthalmology\/fullarticle\/2696743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T17:46:29Z","timestamp":1661795189000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.3352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3352","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}